News

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...
Explore the groundbreaking achievements in quantum as Kipu Quantum and IonQ solve a complex protein folding problem on ...
Explore the exciting advancements in organoids with the successful growth of liver tissue that includes internal blood ...
Explore the latest research on Parkinson's and a key brain protein that may lead to new treatments for this common condition.
Discover the newly identified organelle called hemifusome and its crucial role in cellular housekeeping and genetic diseases.
Explore the link between α2,6-sialyltransferase-I and Alzheimer's disease progression. Understand the new findings on ...
Despite the results, the researchers believe that AI-driven approaches offer a new way forward. Their preprint outlines a ...
A team of scientists at POSTECH have successfully developed a three-dimensional brain model that closely replicates the human brain’s structure and function. Their groundbreaking study was published ...
Under the agreement, Chiesi obtains a worldwide, royalty-bearing license to develop and commercialise two BBB-penetrant ERTs from Key2Brain. These therapies are built on a prior research collaboration ...
Fauna Bio has announced the launch of Fauna Brain, a new AI platform designed to accelerate drug target discovery and streamline early-stage research and development. Building on the company’s ...
This episode, ‘ Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials,’ will explore the challenges and successes of moving promising drug candidates from preclinical ...
DenovAI, an AI-first biotechnology company, has published a new study in Molecular Systems Biology demonstrating the power of its novel de novo protein design tool. The study introduces an advanced AI ...